All In Biotech

Free tool

FAERS Monitor: Exforge Hct

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022314 or its brand name (Exforge Hct, Amlodipine Besylate, Hydrochlorothiazide, Valsartan). Reports on generic versions are filed under their own applications.

Reports

3,664

Serious

3,408

93% of reports

Hospitalization

993

Death reported

502

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood pressure increased378
  • death256
  • hypertension231
  • wrong technique in product usage process227
  • malaise210
  • off label use191
  • diabetes mellitus188
  • dizziness175
  • drug ineffective174
  • headache173
  • blood pressure decreased170
  • fatigue146
  • feeling abnormal138
  • fall134
  • cerebrovascular accident126

Reports by year received

View as table
YearReports
20094
201048
2011158
2012310
2013216
2014228
2015205
2016262
2017211
2018252
2019252
2020346
2021386
2022335
2023237
202485
202569
202660

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,495 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure decreasedSignal17014.712.72,162
blood pressure increasedSignal37814.212.94,657
diabetes mellitusSignal18814.212.32,294
wrong technique in product usage processSignal2276.45.71,046
hypertensionSignal2316.35.51,026
cerebrovascular accidentSignal1264.33.6315
feeling abnormalSignal1383.32.8222
malaiseSignal2102.72.4237
fallSignal1342.32.0100
dizzinessSignal1752.01.791
death2561.71.577
headache1731.61.438
off label use1911.31.110
fatigue1461.10.91
drug ineffective1740.80.714

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.